Pyxis Oncology (PYXS) Non Operating Income (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Non Operating Income data on file, last reported at $1.3 million in Q4 2025.

• Non Operating Income for Q4 2025 came in at $1.3 million, down 44.64% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.2 million (down 37.93% YoY), and the FY2025 annual result was $6.2 million, down 37.93% from the prior year.
• Non Operating Income eased to $1.3 million in Q4 2025 per PYXS's latest filing, from $1.5 million in the prior quarter.
• Over five years, Non Operating Income peaked at $2.7 million in Q2 2024 and troughed at -$2.6 million in Q3 2021.
• A 5-year average of $1.1 million and a median of $1.7 million in 2023 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2021 and 2023: Non Operating Income tumbled 255500.0% in 2021, then jumped 18911.11% in 2023.
• A 5-year view of Non Operating Income shows it stood at -$403000.0 in 2021, then jumped by 564.52% to $1.9 million in 2022, then climbed by 15.92% to $2.2 million in 2023, then rose by 7.56% to $2.3 million in 2024, then tumbled by 44.64% to $1.3 million in 2025.
• Business Quant data shows PYXS's Non Operating Income at $1.3 million in Q4 2025, $1.5 million in Q3 2025, and $1.7 million in Q2 2025.